arrow
L

Laura Van Gerven

university hospitals leuven
H指数:31
被引数:3,911

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Surgical Management of Non-Allergic Rhinitis—An EAACI Task Force Position Paper

非过敏性鼻炎的外科治疗——EAACI工作组立场文件

2026-07-010
OAAI
The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Utricaria, and Chronic Rhinosinusitis With Nasal Polyps

首个用于过敏领域的生物类似药:CT-P39(Omlyclo-Omalizumab-Igec)适用于哮喘、慢性自发性荨麻疹和伴有鼻息肉的慢性鼻窦炎

2026-04-250
PRE
Indication for biologic treatment in a real-world cohort of chronic rhinosinusitis patients according to international recommendations: Evidence from the European CRS outcome registry (CHRINOSOR)

根据国际推荐,真实世界中慢性鼻窦炎患者生物治疗适应症的指示:来自欧洲CRS结局登记处(CHRINOSOR)的证据

2026-04-010
OA
The Unmet Need of Olfactory Testing in Inflammatory Disorders of the Upper Airways—An EAACI Position Paper

上气道炎症性疾病中嗅觉测试的未满足需求——EAACI立场文件

2026-02-020
PRE
Artificial Intelligence (AI)-assisted readout method for the evaluation of skin prick automated test results

人工智能(AI)辅助的皮肤点刺自动化试验结果评估读数方法

2025-10-010
OAAI
Characterization of Chronic Rhinosinusitis Patients Based on Markers of Type 2 Inflammation: Findings From the European CRS Outcome Registry (CHRINOSOR)

基于2型炎症标志物的慢性鼻窦炎患者特征分析:欧洲CRS结局登记研究(CHRINOSOR)的结果

2025-08-310
OAAI
Otitis Media With Effusion (OME) and Eustachian Tube Dysfunction: The Role of Allergy and Immunity-An EAACI Position Paper

分泌性中耳炎(OME)与咽鼓管功能障碍:过敏与免疫的作用——EAACI立场文件

2025-04-170
PREAI
Professor Peter Valentin Tomazic, Graz, Austria

Peter Valentin Tomazic教授,奥地利格拉茨

2024-06-250
PRE
Stability of magistral phage preparations before therapeutic application in patients with chronic rhinosinusitis, sepsis, pulmonary, and musculoskeletal infections

在慢性鼻-鼻窦炎,败血症,肺部和肌肉骨骼感染患者中治疗应用前治安噬菌体制剂的稳定性

2023-12-129
OAAI
Chronic Rhinosinusitis Outcome Registry (CHRINOSOR): Establishment of an International Outcome Registry Driven by mHealth Technology
2023-02-016
OAAI